Historically, only relatively low-throughput or expensive methods have been available to measure cell migration. Hepatocyte growth factor (HGF) is a ligand for the tyrosine kinase receptor Met that, in addition to mediating proliferation and survival, increases cell motility and metastasis. The authors have developed a high-throughput imaging assay for measuring inhibition of HGF-induced scattering in human HPAF-II pancreatic adenocarcinoma cells. Following treatment with test compounds and HGF for 24 h, cells are labeled with a nuclear stain and imaged at 10× magnification. The proximity of neighboring nuclei is measured, and the distribution of internuclear distances across each field of view is used to calculate the fraction of scattered cells. This method of analysis can be extended to other cell types and signaling pathways and, compared with other membrane-based migration assays currently available, the assay is significantly lower in cost, is less labor intensive, and provides higher throughput. (Journal of Biomolecular Screening 2008:847-854) 
INTRODUCTION
I N ADDITION TO DEREGULATED GROWTH, a hallmark of oncogenic transformation of solid tissue is a loss of anchorage dependence and an increase in cellular motility, often leading to metastasis. 1, 2 Consequently, assays to detect and measure changes in cell motility are key tools in assessing the anticancer activity of potential therapeutics. Historically, only relatively low-throughput and expensive methods have been available to measure cell movement, involving detection of cells migrating either through membranes or soft agar or over plastic surfaces. Direct manual observation of the behavior of cells growing on plastic microplates or in soft agar, for example, suffers from a lack of high-throughput quantification. Semi-automated methods exist but, for technical reasons, have been relatively low throughput. 3 Assays based on Boyden chamber-type experiments 4 directly monitoring the transmembrane migration of fluorescently labeled cells have been fully automated but require relatively costly microplates with fluorescence-blocking membrane inserts. 5, 6 Migration assays using transparent or translucent porous surfaces are somewhat less expensive, but quantification is less straightforward than direct fluorescence imaging. Complete recording of cell tracks in multiple dimensions is technically feasible but very computationally intensive (e.g., see Bahnson et al. 7 ). Recent efforts to quantify cell migration in wound-healing assays have been successful, 8, 9 but the throughput is still limited and requires specialized instrumentation and software. A further limitation of mobility studies is the historical reliance on physiological surrogate cell lines. Many high-throughput cell mobility experiments have focused on the Madin-Darby canine kidney (MDCK) cell line (see, e.g., Chen 3 ).
Met, 10 a member of the receptor tyrosine kinase family, and its ligand, hepatocyte growth factor (HGF, aka scatter factor [SF]), [11] [12] [13] play key roles in cell proliferation, survival, differentiation, and motility. [14] [15] [16] [17] As such, they are required for normal mammalian development and tissue repair. Depending on the cell type and culture conditions, Met signaling triggers several cellular responses in vitro, including the induction of proliferation, and antiapoptotic responses. Epithelial cells in particular respond by "scattering," a phenotype that includes colony dispersal, epithelial-mesenchymal transition, and increases in motility. 16 The dysregulation of Met and HGF function is implicated in oncogenesis and tumor metastasis. [14] [15] [16] [17] Overexpression of the receptor and its ligand, amplification of the MET gene, and activating Met mutations leading to aberrant Met signaling have been found in numerous human cancer types. Correlation between high levels of Met/HGF expression and tumor invasiveness has been suggested, and Met/HGF expression correlates with poor prognosis in many cancers (for review, see Birchmeier et al. 16 ). Given the evidence for Met involvement in human cancer, developing a selective small-molecule inhibitor of Met kinase activity is of high therapeutic interest.
In a recent drug discovery program, we employed a panel of in vitro screening assays to characterize Met small-molecule inhibitors. These included an initial in vitro biochemical assay to measure Met-mediated tyrosine phosphorylation of a synthetic peptide. This high-throughput assay allowed rapid screening of 1.2 million compounds. In the lead optimization phase of the program, compounds with potent inhibitory activity were tested in a secondary biological assay measuring growth inhibition of the Met-amplified cell line GTL-16. [18] [19] [20] Given the role of Met in both proliferation and migration, we were interested in developing an additional biological assay to measure HGF-dependent motility.
HGF stimulates a dramatic morphological change and scattering phenotype in many cell types, including the human pancreatic adenocarcinoma cell line HPAF-II. [21] [22] [23] HGF activates Met, resulting in the recruitment of scaffolding proteins Grb2 (growth factor receptor bound protein 2) and Gab1 (growth factor receptor bound protein 2-associated binder 1), with subsequent activation of several pathways, including Gab1-Crk-C3G and Grb2-Ras-Rac1/ Cdc42-PAK (for review, see Birchmeier et al. 16 ). The cell-scattering response is a direct consequence of Met activation and is therefore a relevant functional phenotypic readout.
We therefore developed a cell mobility assay using an imaging platform, the IN Cell Analyzer 1000 automated microscope system (GE Healthcare Bio-Sciences, Piscataway, NJ). The high-content scatter assay described here is simple, cost-effective, and suitable for measuring the inhibition of HGF-induced scattering in HPAF-II cells with high throughput. We also show the utility of a distribution-based data analysis method by taking advantage of the IN Cell Analyzer 1000's software capability to quantify data from single cells within a population.
METHODS

Cell culture
The human pancreatic adenocarcinoma cell line HPAF-II (ATCC CRL-1997), 21, 22 obtained from American Type Culture Collection (ATCC, Manassas, VA), was grown in Dulbecco's modified Eagle's medium (DMEM) (Gibco BRL, Gaithersburg, MD) containing 4.5 g/L glucose, 4 mM L-glutamine, and 1 mM sodium pyruvate, supplemented with 10% (v/v) fetal bovine serum (Gibco BRL), 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells were plated at a density of 8000 cells per well in 90 μL in blacksided, clear-bottomed 96-well microplates (Corning Life Sciences, Acton, MA) and allowed to settle overnight at 37 °C in a humidified atmosphere of 5% CO 2 prior to treatments.
Compound treatments
Test compounds were diluted to 10× (final concentration) in medium such that addition of 10 μL to cells would yield the desired final concentrations. Following 1 h incubation at 37 °C in a humidified atmosphere of 5% CO 2 , 25 μL of 5× (final concentration) recombinant human HGF (R&D Systems, Minneapolis, MN) diluted in medium was added to the cells to give a final concentration of 12.5 ng/mL. The cells were further incubated at 37 °C in an atmosphere of 5% CO 2 for at least 20 h, washed with phosphate-buffered saline (PBS; Gibco BRL), and fixed in ice-cold methanol (Sigma, St. Louis, MO), and the nuclei were then stained with 10 μg/mL Hoechst 33342 (Molecular Probes, Carlsbad, CA). SU11274 and Iressa (gefitinib) were purchased from Calbiochem (San Diego, CA) and Beth Israel Hospital Pharmacy (Boston, MA), respectively.
Image acquisition and analysis
The IN Cell Analyzer 1000 automated cellular imaging system (GE Healthcare Bio-Sciences) was used to acquire images in the Hoechst 33342 channel using excitation filter D360/40 and emission filter HQ460/40 with a 10× objective by exposing fields for 500 ms. For each well, 3 image fields were acquired and then analyzed using the IN Cell Analyzer 1000 morphology analysis module. At least 200 to 300 cells were required for good results, and 3 fields typically included 1000 cells or more, ensuring that the odd random empty field would not significantly affect the calculations. The measure of internuclear distance is the parameter "Spacing SOI," a single average distance value calculated for each cell between it and its nearest neighbors, determined using the sphere of influence (SOI) adjacency rule (see Fig. 2a ). For the set of points S (e.g., cell nucleus centers), points I ∈ S and J ∈ S are referred to as adjacent if an adjacency rule is satisfied. For the SOI adjacency rule, denote I* ∈ S as the point nearest to I and J* ∈ S as the point nearest to J. Denote SOI(I) sphere of radius ||I, I*|| centered by I and SOI (J) sphere of radius ||J, J*|| centered by J. Points I and J are adjacent by SOI if spheres SOI(I) and SOI(J) intersect. In this application to cell scattering, the sphere simplifies to a circle. The average SOI distance is calculated by averaging the magnitude of all the vectors between a given point and its adjacent neighbors. In the example shown in Figure 2a , cell H is adjacent to cells C, D, E, and G. The pairwise distances HC, HD, HE, and HG (red arrows) are then averaged to produce a single average SOI value for cell H. The calculation is done for every cell nucleus in the field of view. The cell-by-cell distribution of the spacing SOI measurement was used to calculate the percentage of scattered cells for each well using an algorithm created with Pipeline Pilot software (SciTegic, San Diego, CA). Cells in HGF-treated wells with an individual Spacing SOI value more than 1 standard deviation above the population mean Spacing SOI value in the non-HGFtreated negative control wells were classified as "scattered." IC 50 values were calculated using a robust 4-parameter fit of the dose-response curve of the percentage of scattered cells plotted as a function of the log of the compound concentration using equations (1) and (2).
The Z′ factor 24 was calculated by equation (3).
where σ max and σ min are standard deviations, and μ max and μ min are the means for the percentage of scattered cells in +HGF and -HGF controls, respectively.
RESULTS
Effect of HGF on the morphology of HPAF-II cells
Under normal culture conditions, HPAF-II cells grow in clumps on the surface of a microplate (Fig. 1a) . Upon treatment with HGF, the cells lose their cell-cell adhesion and increase their motility. After incubation overnight, the result is a scattered phenotype, with the cells uniformly distributed across the surface (Fig.  1b) . Treatment with various concentrations of HGF for 20 h shows that the scatter effect is concentration dependent, with an apparent EC 50 of approximately 300 pg/mL HGF (Fig. 1c) . Inhibition of the HGF receptor can thus be measured by assessing a compound's ability to block this HGF-induced scatter effect.
Population distribution analysis method to measure cell scattering
The Spacing_SOI mean values of untreated control and HGFtreated wells were 39 and 55 pixels, respectively ( Table 1) . This represented a less than 2-fold change in the mean internuclear distance of the cell populations. Even though significant differences were observed in the Spacing_SOI value between individual cells that are tightly clumped and ones that are scattered, when these values are averaged over the entire well populations, the difference is masked. Thus, the data indicate that such an analysis would not be robust and emphasize the need for an alternative approach to analyze the data. Figure 2c shows superimposed distribution histograms of Spacing_SOI of cells in representative untreated (blue) and HGF-treated (red) wells. The distribution in the HGF-treated population displays a distinctive broad tail and rightward shift toward a larger internuclear distance. Because almost all cells are in contact, a "clumped" population has significantly fewer cells with a large Spacing_SOI value. By setting an SOI distance threshold above which cells are classified as "scattered," the difference between untreated and HGF-treated wells is much more apparent (Fig. 2d) . To identify scattered cells, we first calculated the population mean and standard deviation of the Spacing_SOI value for the set of untreated (i.e., clumped) wells. Individual cells with Spacing SOI values more than 1 standard deviation higher than the clumped control mean are then classified as "scattered." In Table 1 , the calculated cutoff to define a scattered cell is 39 + 16 = 55 pixels. The percentage of scattered cells above this cutoff in the untreated well is 6% compared with 47% in the HGF-treated well. With the application of this classification scheme, a much improved assay window results, allowing us to validate the assay by testing a subset of small-molecule Met inhibitors.
Assay validation
The utility of the assay was assessed by testing Met inhibitors with a range of potencies, as measured previously with a membrane migration assay based on the FluoroBlok™ Multiwell Insert System (BD Falcon™). Figure 3a shows representative microscopic images of HPAF-II cells treated with 4 compounds that inhibit HGF-induced scattering with a range of IC 50 values. The dose-response curves for these 4 compounds, along with 5 other representative compounds from the same structural class, are shown in Figure 3b . Percentage inhibition was normalized to the positive (100% scattered) HGF-treated controls without compound treatment. To independently confirm that inhibition of scattering was specific for the Met pathway, we also tested a known Met inhibitor, SU11274, 25 along with an unrelated tyrosine kinase inhibitor, Iressa (an inhibitor of EGFR). 26 As expected, Iressa had little effect (IC 50 = 31 μM), whereas SU11274 inhibited cell scattering quite potently (IC 50 = 370 nM). Thus, the assay was sensitive enough to distinguish between specific Met inhibitors with IC 50 values from the nano-to micromolar range ( Table 2) .
Further validation was performed by testing a larger set of compounds in the scatter assay and comparing IC 50 values with those obtained in the FluoroBlok™ membrane migration assay. The IC 50 values from >90% of the 69 compounds tested agreed within a half log in both assays, showing a good correlation (Fig. 4a) . The Z′ 24 and signal-to-background ratio (S/B) for sixteen 96-well plates of experiments conducted on 5 different days were 0.67 ± 0.12 and 8.0 ± 1.2, respectively. Figure 4b shows IC 50 values measured for a single control compound over 8 months, with a mean of 430 ± 130 nM. These results demonstrate that our assay is reproducible, and the performance is suitable for screening.
Supporting the lead optimization of a small-molecule Met inhibitor
The simplicity and robustness of the above assay for quantifying HGF-induced scattering in HPAF-II cells made it particularly suitable as a screening tool. Consequently, the method was used as a secondary cell-based functional assay for supporting structure-activity relationship (SAR) optimization of a Met small-molecule inhibitor. The overall strategy for identifying potent Met inhibitor compounds used a primary enzymatic assay followed by cell-based functional assays. These secondary assays included a viability assay using the Met-dependent human gastric cancer cell line GTL-16 and the HGF-induced HPAF scatter assay. The GTL-16 cell line contains amplified Met, which is constitutively activated in a ligand-independent fashion. 27 The IC 50 values of the program compounds tested in the HGFinduced scatter assay correlate well with the IC 50 values obtained in the GTL-16 viability assay (Fig. 4c) . IC 50 values measured for most of the compounds in the 2 cell-based assays were comparable to within a half log shift of each other, with a calculated mean ratio (MR) of 0.54 and a minimum significant ratio (MSR) 28 of 3.64. This provides independent evidence that most of the antiproliferative effects seen in the ligand-independent GTL-16 cells were mechanism based and not due to toxicity. In addition, the scatter assay can be further multiplexed to determine effects on cell number. Although the assay was conducted with a relatively short incubation time of ~24 h after drug addition, we identified several compounds that caused a significant decrease in cell number. Because the growth of HPAF cells is not inhibited by Met-specific small molecules or shRNA (data not shown), this allowed us to use the scatter assay as an additional counterscreen to verify that the lead series compounds were not acutely cell toxic. Overall, the HGF, hepatocyte growth factor; SOI, sphere of influence. a. Scattered cells calculated as described in the text.
correlation data show that activity in the scatter assay is predictive of a compound's potency of inhibition of the Met pathway.
DISCUSSION
High-content screening assays have become an integral part of drug discovery, offering information-rich data on drug behavior in a cellular environment. We describe here a novel high-content assay for the identification of small-molecule Met inhibitors based on the measurement of cell scattering. HGF modulates a wide range of biological activities, including cell growth, motility, and morphological changes through the Met tyrosine kinase receptor. In fact, most cells respond to HGF/SF, 23 and deregulation of HGF and Met activity are observed in numerous cancers. 16 We used an automated imaging platform's capability to extract data from . There is only a small shift in the mean spacing (SOI) between the 2 populations but a large tail toward longer distances in the scattered population. (d) Classification of "scattered" cells. This overlapping plot shows the distribution of Spacing SOI values for HGF-treated scattered (red) and untreated clumped (blue) control wells. The thin dotted line indicates the mean SOI value for all the untreated control wells on a single microplate, and the thick solid vertical line is the mean SOI + 1 standard deviation cutoff. A 1 standard deviation threshold provided the optimal combination of signal to background (S/B) and Z′ (data not shown). This statistical approach identifies a significant difference in the percentage of "scattered" cells between the no HGF (6%) and HGFtreated (47%) control wells. single cells and developed an analysis method based on distribution of the measured spacing parameter within a cell population. This method greatly enhanced the signal window of the assay compared with the population mean analysis. This type of cell analysis is broadly applicable to a range of other high-content assays for detecting changes within a population that might otherwise be masked by averaging. In addition, the assay could easily be miniaturized to a 384-or 1536-well format, if desired. Finally, acute nonspecific effects on cell viability can also be eliminated as a source of scatter inhibition by monitoring the number of cells in each well or by multiplexing with toxicity markers. Current commercially available assays for measuring cell migration or invasion are expensive and/or labor intensive. The scatter assay described here is simple, robust, and cost-effective with automated high-throughput capabilities. It has been successfully implemented as a secondary cell-based functional assay in a 96-well format for screening lead compounds for Met inhibition. We found good correlation between the scatter assay and a Met-dependent cell viability assay, suggesting that this class of Met inhibitors functions in a pathway-specific manner. We observed a significant correlation for the majority of the compounds tested and thus identified candidates suitable for preclinical development. In addition to facilitating Met small-molecule inhibitor discovery, the scatter assay reported here can help researchers to better understand signal transduction pathways responsible for mediating cell scattering. Thus, the scatter assay may be useful for further identifying downstream targets for therapeutic intervention and can aid in the design of antimetastasis compounds. 
